Aeovian Pharmaceuticals
San Francisco, United States· Est. 2020
Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Private Company
Total funding raised: $40M
About
Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Small Molecules
Funding History
2Total raised:$40M
Series A$35MSep 15, 2022
Seed$5MMar 15, 2021